Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
Phenytoin toxicity and thyroid dysfunction
New Zealand Medical Journal, 10/08/09
Betteridge T et al. – A 48–year–old woman with known epilepsy presented to the Emergency Department with a 1–day history of decreasing coordination, impaired speech, and recurrent falls. Phenytoin levels were measured and found to be grossly elevated at 170 mmol/L. A diagnosis of phenytoin toxicity was made and she was treated by withdrawing the medication. During admission she was found to be profoundly hypothyroid despite being on adequate thyroid replacement therapy. Normalisation of phenytoin levels was associated with return of euthyroidism. The interaction between phenytoin, thyroid function, and thyroid replacement therapy is discussed.
Related Articles
Interindividual variability of drug transporters: Impact on opioid treatment in chronic renal failure
European Journal of Pain, 11/12/09
Relevance Score: 80%
Unusual presentation of iatrogenic phenytoin toxicity in a newborn
Journal of Medical Toxicology, 11/11/09
Relevance Score: 80%
Phenytoin-facilitated hypoglycaemia in ESRF
British Journal of Renal Medicine, 10/26/09
Relevance Score: 80%
Drug-Induced Steatohepatitis Leading to Cirrhosis: Long-Term Toxicity of Amiodarone Use
Seminars in Liver Disease, 10/16/09
Relevance Score: 80%
Rituximab in the Treatment of Thyroid Eye Disease: Science Fiction
Orbit - The International Journal on Orbital Disorders, Oculoplastic and Lacrimal Surgery, 11/12/09
Relevance Score: 79%
Today in Adverse Drug Reactions...keeping you current
Receive free subspecialty "5-minute updates" via email
Pregabalin, celecoxib, and their combination for treatment of chronic low-back pain
Journal of Orthopaedics and Traumatology, 11/24/09
Enzyme therapy in Fabry disease: severe adverse events associated with anti-agalsidase cross-reactive IgG antibodies
British Journal of Clinical Pharmacology, 11/24/09
Appraising the post-marketing safety of medicines: A description of national and international pharmacovigilance with a focus on medicines used in chronic pain
Current Anaesthesia and Critical Care, 11/24/09
Today in Other Drugs...keeping you current
Receive free subspecialty "5-minute updates" via email
Persistence with injectable antidiabetic agents in members with type 2 diabetes in a commercial managed care organization
Current Medical Research and Opinion, 11/25/09
Anti-relapse medications: Preclinical models for drug addiction treatment
Pharmacology & Therapeutics, 11/25/09
Glibenclamide-related excess in total and cardiovascular mortality risks: Data from large Ukrainian observational cohort study
Diabetes Research and Clinical Practice, 11/25/09
Sponsor
Article Search
Sponsor


See Latest Articles


